Works matching IS 14628902 AND DT 2024 AND VI 26


Results: 708
    1

    Issue Information.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, p. 1, doi. 10.1111/dom.15527
    Publication type:
    Article
    2

    Issue Information.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, p. 1, doi. 10.1111/dom.15527
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    10

    Effects of glucagon‐like peptide‐1 receptor agonists on glycated haemoglobin and continuous glucose monitoring metrics as adjunctive therapy to insulin in adults with type 1 diabetes: A meta‐analysis of randomized controlled trials.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 12, p. 6043, doi. 10.1111/dom.15979
    By:
    • Karakasis, Paschalis;
    • Koufakis, Theocharis;
    • Patoulias, Dimitrios;
    • Barkas, Fotios;
    • Klisic, Aleksandra;
    • Mitrovic, Milena;
    • Doumas, Michael;
    • Papanas, Nikolaos;
    • Popovic, Djordje S.
    Publication type:
    Article
    11

    The coexistence of low muscle mass and obesity evaluated by dual energy X‐ray absorptiometry, rather than low muscle mass or obesity alone, is associated with macrovascular but not microvascular complications in patients with type 2 diabetes mellitus

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 12, p. 6034, doi. 10.1111/dom.15978
    By:
    • Li, Han;
    • Su, Weijuan;
    • Zheng, Zeyu;
    • Li, Jia;
    • Wang, Shunhua;
    • Chen, Zheng;
    • Zhang, Yuxian;
    • Huang, Bingkun;
    • Lyu, Fuping;
    • Yan, Fangfang;
    • Huang, Caoxin;
    • Lin, Mingzhu;
    • Shi, Xiulin;
    • Li, Xuejun
    Publication type:
    Article
    12
    13
    14
    15
    16

    Tirzepatide, a dual glucose‐dependent insulinotropic polypeptide/glucagon‐like peptide 1 receptor agonist, exhibits favourable effects on pancreatic β‐cells and hepatic steatosis in obese type 2 diabetic db/db mice.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 12, p. 5982, doi. 10.1111/dom.15972
    By:
    • Iwamoto, Yuichiro;
    • Kimura, Tomohiko;
    • Dan, Kazunori;
    • Iwamoto, Hideyuki;
    • Sanada, Junpei;
    • Fushimi, Yoshiro;
    • Katakura, Yukino;
    • Shimoda, Masashi;
    • Yamasaki, Yuki;
    • Nogami, Yuka;
    • Shirakiya, Yoshiko;
    • Nakanishi, Shuhei;
    • Mune, Tomoatsu;
    • Kaku, Kohei;
    • Kaneto, Hideaki
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    Coronary artery disease risk prediction by combined stratification of low‐density lipoprotein‐cholesterol and high‐density lipoprotein‐cholesterol levels across different glucose statuses.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 12, p. 5845, doi. 10.1111/dom.15956
    By:
    • Yachida, Junko;
    • Fujihara, Kazuya;
    • Harada Yamada, Mayuko;
    • Kobayashi, Ayako;
    • Khin, Lay Mon;
    • Takizawa, Hiroki;
    • Yamamoto, Masahiko;
    • Kitazawa, Masaru;
    • Matsubayashi, Yasuhiro;
    • Yamada, Takaho;
    • Kodama, Satoru;
    • Sone, Hirohito
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40

    Associations between cuprotosis‐related genes and the spectrum of metabolic dysfunction‐associated fatty liver disease: An exploratory study.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 12, p. 5757, doi. 10.1111/dom.15946
    By:
    • Yuan, Hai‐Yang;
    • Liu, Wen‐Yue;
    • Feng, Gong;
    • Chen, Sui‐Dan;
    • Jin, Xin‐Zhe;
    • Chen, Li‐Li;
    • Song, Zi‐Jun;
    • Li, Ke;
    • Byrne, Christopher D.;
    • Targher, Giovanni;
    • Tian, Na;
    • Li, Gang;
    • Zhang, Xin‐Lei;
    • George, Jacob;
    • Zhou, Meng;
    • Wang, Fudi;
    • Zheng, Ming‐Hua
    Publication type:
    Article
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50